J.M. Morrison

1.1k total citations
30 papers, 773 citations indexed

About

J.M. Morrison is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, J.M. Morrison has authored 30 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in J.M. Morrison's work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (4 papers) and Bone health and treatments (3 papers). J.M. Morrison is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (4 papers) and Bone health and treatments (3 papers). J.M. Morrison collaborates with scholars based in United Kingdom, United States and Australia. J.M. Morrison's co-authors include Nigel Bundred, W A Ratcliffe, J. G. Ratcliffe, Shana M. Coley, Joseph P. Hanig, Malcolm Reed, Stephen Krop, M.S. Dover, Anthony Howell and Richard A. Walker and has published in prestigious journals such as Circulation, The American Journal of Cardiology and British Journal of Cancer.

In The Last Decade

J.M. Morrison

30 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.M. Morrison United Kingdom 16 318 162 155 137 124 30 773
Maureen O’Connell United States 17 69 0.2× 118 0.7× 152 1.0× 87 0.6× 48 0.4× 20 983
Michael Gallagher Ireland 16 232 0.7× 116 0.7× 197 1.3× 388 2.8× 30 0.2× 30 941
Yafeng Dong United States 18 105 0.3× 60 0.4× 124 0.8× 273 2.0× 48 0.4× 42 903
Minoru Ito Japan 16 52 0.2× 245 1.5× 82 0.5× 227 1.7× 44 0.4× 36 945
Jennifer Sprague United States 12 187 0.6× 287 1.8× 53 0.3× 125 0.9× 37 0.3× 20 805
Massimo Vaghi Italy 19 393 1.2× 28 0.2× 106 0.7× 240 1.8× 36 0.3× 51 1.1k
Karolina Jabłońska Poland 18 265 0.8× 79 0.5× 138 0.9× 290 2.1× 40 0.3× 50 890
P. M. van Koetsveld Netherlands 22 276 0.9× 132 0.8× 107 0.7× 240 1.8× 29 0.2× 41 1.2k
Guan Wang China 15 89 0.3× 82 0.5× 85 0.5× 166 1.2× 114 0.9× 78 670
Masato Takahashi Japan 14 112 0.4× 214 1.3× 181 1.2× 118 0.9× 21 0.2× 38 836

Countries citing papers authored by J.M. Morrison

Since Specialization
Citations

This map shows the geographic impact of J.M. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Morrison more than expected).

Fields of papers citing papers by J.M. Morrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Morrison. The network helps show where J.M. Morrison may publish in the future.

Co-authorship network of co-authors of J.M. Morrison

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Morrison. A scholar is included among the top collaborators of J.M. Morrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Morrison. J.M. Morrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spooner, D., Deborah Stocken, Sarah Bathers, et al.. (2012). A Randomised Controlled Trial to Evaluate both the Role and the Optimal Fractionation of Radiotherapy in the Conservative Management of Early Breast Cancer. Clinical Oncology. 24(10). 697–706. 22 indexed citations
2.
Edwards, Robert, W A Ratcliffe, J. Walls, et al.. (1995). Parathyroid hormone-related protein (PTHrP) in breast cancer and benign breast tissue. European Journal of Cancer. 31(3). 334–339. 13 indexed citations
3.
Stonelake, Paul, James Powell, Janet Dunn, et al.. (1995). Influence of timing of surgery during menstrual cycle on survival of premenopausal women with operable breast cancer. The Breast. 4(1). 19–24. 9 indexed citations
4.
Spooner, D., J.M. Morrison, David Ellis, et al.. (1995). 16. The role of radiotherapy in early breast cancer (stage I). A West Midlands Breast Group prospective randomized collaborative study (BR 3002).. The Breast. 4(3). 231–232. 9 indexed citations
5.
Stonelake, Paul, N.J. Bundred, Peter R. Baker, et al.. (1994). Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer. European Journal of Cancer. 30(1). 5–11. 24 indexed citations
6.
Walls, J., et al.. (1993). Parathyroid hormone-related protein: cytosol extraction in breast cancer and normal breast tissue. The Breast. 2(3). 203–203. 1 indexed citations
7.
Dunn, Janet, et al.. (1993). Impact of adjuvant chemotherapy in breast cancer on response to tamoxifen at relapse. Cancer Treatment Reviews. 19. 11–19. 3 indexed citations
8.
Bundred, Nigel, et al.. (1993). Smoking and periductal mastitis.. BMJ. 307(6907). 772–773. 33 indexed citations
9.
Morrison, J.M., K. Kelly, Anthony Howell, et al.. (1992). West Midlands Oncology Association trial of adjuvant chemotherapy in node-negative breast cancer.. PubMed. 85–8. 5 indexed citations
10.
Bundred, Nigel, J.M. Morrison, W A Ratcliffe, et al.. (1992). Parathyroid hormone related protein and skeletal morbidity in breast cancer. European Journal of Cancer. 28(2-3). 690–692. 96 indexed citations
11.
Zaret, Barry L., Frans J. Th. Wackers, Michael L. Terrin, et al.. (1992). Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) II study. The American Journal of Cardiology. 69(1). 1–9. 29 indexed citations
12.
13.
Howell, Anthony, et al.. (1984). Dibromodulcitol, mitomycin C and vinblastine (DMV) chemotherapy in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 20(7). 873–876. 8 indexed citations
14.
Muller, James E., Zoltan G. Turi, David L. Pearle, et al.. (1984). Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.. Circulation. 69(4). 728–739. 100 indexed citations
15.
Smith, Stacy, et al.. (1982). The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy. British Journal of Cancer. 46(5). 757–764. 17 indexed citations
16.
Cove, D.H., et al.. (1981). Serum proteins as tumour markers for breast cancer. British Journal of Cancer. 43(4). 542–545. 6 indexed citations
17.
Woods, KL, D.H. Cove, J.M. Morrison, & David A. Heath. (1979). The investigation of lactalbumin as a possible marker for human breast cancer. European Journal of Cancer (1965). 15(1). 47–51. 17 indexed citations
18.
Morrison, J.M.. (1979). The West Midlands co-operative trial of adjuvant chemotherapy for operable breast cancer. Cancer Treatment Reviews. 6. 87–90. 7 indexed citations
19.
Hanig, Joseph P., et al.. (1976). Observations on Hexachlorophene-Induced Paralysis in the Cat and Its Antagonism by Hypertonic Urea. Experimental Biology and Medicine. 152(2). 165–169. 12 indexed citations
20.
Hanig, Joseph P., J.M. Morrison, & Stephen Krop. (1971). Increase of blood-brain barrier permeability to catecholamines by dimethyl sulphoxide in the neonate chick. Journal of Pharmacy and Pharmacology. 23(5). 386–387. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maureen O’Connell Breakdown of academic impact, for papers by Michael Gallagher Breakdown of academic impact, for papers by Yafeng Dong Breakdown of academic impact, for papers by Minoru Ito Breakdown of academic impact, for papers by Jennifer Sprague Breakdown of academic impact, for papers by Massimo Vaghi Breakdown of academic impact, for papers by Karolina Jabłońska Breakdown of academic impact, for papers by P. M. van Koetsveld Breakdown of academic impact, for papers by Guan Wang Breakdown of academic impact, for papers by Masato Takahashi
Rankless by CCL
2026